Article Details

Degron Therapeutics Co-Founder Provides New Strategy for Molecular Glue in Tumor ... - BioSpace

Retrieved on: 2022-06-27 12:32:16

Tags for this article:

Click the tags to see associated articles and topics

Degron Therapeutics Co-Founder Provides New Strategy for Molecular Glue in Tumor ... - BioSpace. View article details on hiswai:

Excerpt

Research published in Cell Chemical Biology showed lenalidomide can enhance ... of the immune system signaling molecule, interleukin-2 (IL2).

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up